Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2019-07-14 16:55:15 UTC |
---|
Last Updated | 2019-10-01 21:42:13 UTC |
---|
CypComp ID | CC02472 |
---|
Compound Information |
---|
Name | BMS-275183 |
---|
Structure Image | |
---|
InChIKey | AHXICHPPXIGCBN-TYVWMPTDSA-N |
---|
PubChem ID | Not Available |
---|
CypCompound Information |
---|
Set | CypBoM Training Set |
---|
Bonds of Metabolism (BoMs) | CYP1A2 | CYP2A6 | CYP2B6 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP2E1 | CYP3A4 | | | | | | | | | - <55,H;Hydroxylation;R1>
- <53,H;Hydroxylation;R2>
- <54,H;Hydroxylation;R3>
- <58,H;Hydroxylation;R4>
- <59,H;Hydroxylation;R5>
- <60,H;Hydroxylation;R6>
|
|
---|
References | - Zhang D, Ly VT, Lago M, Tian Y, Gan J, Humphreys WG, Comezoglu SN: CYP3A4-mediated ester cleavage as the major metabolic pathway of the oral taxane 3'-tert-butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4- O-methoxycarbonyl-paclitaxel (BMS-275183). Drug Metab Dispos. 2009 Apr;37(4):710-8. doi: 10.1124/dmd.108.024398. Epub 2009 Jan 21. [PubMed:19158314 ]
|
---|
Download File | CC02472.sdf |
---|